Despite advances in the detection, pathological diagnosis and therapeutics of lung cancer,
many patients still develop advanced, incurable and progressively fatal disease. As …

Background In the United States, lung cancer is a major health problem that is associated
with significant patient distress and often limited survival, with some exceptions. The …

Evidence-based practice guidelines for end-of-life care for patients with lung cancer have
been previously available only from the British health-care system. Currently in this setting …

Objective To develop clinical practice guidelines for application of palliative care
consultation, quality-of-life measurements, and appropriate bereavement activities for …

Lung cancer is the leading cause of death due to malignancy. Although lung cancer
mortality has been decreasing in recent years, it remains substantially higher than other …

The evidence base demonstrating the benefits of an early focus on palliative care for
patients with serious cancers, including advanced lung cancer, is substantial. Early …

Advanced restrictive lung diseases remain a challenge for both the clinician and patient
alike. Because there are few available treatment options that prolong survival for patients …

The management of advanced lung cancer is changing rapidly, with new drug approvals
occurring almost monthly. The average age of a newly diagnosed patient with advanced …

Palliative care is appropriate for patients at any point in a serious illness. Unlike hospice,
palliative care is not limited by prognosis and may be provided at the same time as disease …

A major barrier to broader public acceptance of palliative care for life-threatening illnesses
has been the reasonable presumption that forgoing aggressive treatment in favour of …